SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Fundamental Home Exercise center Hardware: Amplify Your Exercises - 2Exclusive new photos from 'Michael' biopic show Jaafar Jackson as King of Pop
- 3Artemis 2 moon rocket gets 'America 250' paint job | Space photo of the day for Dec. 23, 2025
- 4'A perfect storm': Airlines cut flights and increase airfares as jet fuel price spikes
- 5Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
- Top Fascinating Organic products: Which One Might You Want to Attempt?
- Vote in favor of the handheld vacuum that you love for its strong attractions!
- It's time for Artemis II to break Apollo 13's distance record. What to know about the moon flyby
- Study finds humans were making fire 400,000 years ago, far earlier than once thought
- Extraordinary Picks for Home Apparatuses: Making Life Simpler
- Presenting Nintendo's New Pastel Bliss Con Tones for Switch Gamers: 3 Smart Choices
- A trip to Colombia in my 20s turned into 8 years freelancing in South America. Here's what I'd do differently.
- Central African Republic's president sworn in for a third term after disputed election
- Must-Have Cooking Machine in Your Kitchen
